Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy: Primary Outcomes from the RECOVERY Study

被引:0
|
作者
Nittala, Muneeswar Gupta [1 ]
Fan, Wenying [1 ]
Velaga, Swetha Bindu [1 ]
Zhou, Brenda [2 ,3 ]
Lampen, Shaun [2 ,3 ]
Rusakevich, Alexander Michael [2 ,3 ]
Ip, Michael S. [1 ]
Wykoff, Charles Clifton [2 ,3 ]
Sadda, Srinivas R. [1 ]
机构
[1] Doheny Eye Inst, Ophthalmol, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Retina Consultants Houston, Blanton Eye Inst, Houston, TX USA
[3] Retina Consultants Houston, Houston Methodist Hosp, Houston, TX USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
6547
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Comment on: Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy
    Ayman G. Elnahry
    Wael A. Yussuf
    Eye, 2022, 36 : 1705 - 1705
  • [32] RETINAL AND PREGNANCY OUTCOMES IN THE PRESENCE OF DIABETIC PROLIFERATIVE RETINOPATHY
    REECE, EA
    LOCKWOOD, CJ
    TUCK, S
    COULEHAN, J
    HOMKO, C
    WIZNITZER, A
    PUKLIN, J
    JOURNAL OF REPRODUCTIVE MEDICINE, 1994, 39 (10) : 799 - 804
  • [33] Peripheral and central capillary non-perfusion in diabetic retinopathy: An updated overview
    Antropoli, Alessio
    Arrigo, Alessandro
    La Franca, Lamberto
    Bianco, Lorenzo
    Barlocci, Eugenio
    Fusi, Emanuele
    Bandello, Francesco
    Battaglia Parodi, Maurizio
    FRONTIERS IN MEDICINE, 2023, 10
  • [34] MEDICARE randomized trial: intravitreal aflibercept treatment versus pan-retinal photocoagulation in the regression of neovascularisation in proliferative diabetic retinopathy
    Tardieu, Guillaume
    Saleh, Maher
    Pebayle, Gil
    Bolet, Maxime
    Ingrand, Pierre
    Leveziel, Nicolas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [35] Laws of physics help explain capillary non-perfusion in diabetic retinopathy
    Stefansson, E.
    Chan, Y. K.
    Bek, T.
    Hardarson, S. H.
    Wong, D.
    Wilson, D. I.
    EYE, 2018, 32 (02) : 210 - 212
  • [36] Laws of physics help explain capillary non-perfusion in diabetic retinopathy
    E Stefánsson
    Y K Chan
    T Bek
    S H Hardarson
    D Wong
    D I Wilson
    Eye, 2018, 32 : 210 - 212
  • [37] Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study
    Babiuch, Amy
    Wykoff, Charles Clifton
    Hach, Jenna
    Srivastava, Sunil
    Talcott, Katherine E.
    Yu, Hannah J.
    Nittala, Muneeswar
    Sadda, SriniVas
    Ip, Michael S.
    Le, Thuy
    Hu, Ming
    Reese, Jamie
    Ehlers, Justis P.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (08) : 1111 - 1115
  • [38] Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
    Young, Benjamin K.
    Johnson, Mark W.
    Wubben, Thomas J.
    JAMA OPHTHALMOLOGY, 2021, 139 (07) : 804 - 805
  • [39] Effects of Intravitreal Aflibercept on Retinal Function and Improvement of Macular Edema Associated With Diabetic Retinopathy
    Ichio, Atsushi
    Sugimoto, Masahiko
    Matsubara, Hisashi
    Mochida, Daiki
    Kato, Kumiko
    Kondo, Mineo
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (11): : 1 - 10
  • [40] Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
    El-Batarny, Ashraf M.
    CLINICAL OPHTHALMOLOGY, 2007, 1 (02): : 149 - 155